The Relative Strength (RS) Rating for MSCI moved into a new percentile Tuesday, as it got a lift from 70 to 73.
IBD's proprietary RS Rating measures market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Decades of market research reveals that the market's biggest winners often have an RS Rating of over 80 as they launch their biggest price moves. See if MSCI can continue to show renewed price strength and clear that threshold.
Can You Really Time The Stock Market?
MSCI is working on a flat base with a 642.45 buy point. See if it can break out in volume at least 40% higher than normal.
Earnings growth increased last quarter from 12% to 14%. But revenue gains fell from 16% to 8%.
MSCI holds the No. 22 rank among its peers in the Financial Services-Specialty industry group. Marex Group, Tiptree and Corpay are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
